Abstract
AimsThe identification of actionable DNA mutations associated with a patient’s tumour is critical for devising a targeted, personalised cancer treatment strategy. However, these molecular analyses are typically performed using tissue...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have